ZBeats
1 known investors
ZBeats is a cardiac technology company offering FDA-cleared electrocardiographic analysis software that transforms ECG signals into structured clinical intelligence for cardiology workflows. The platform serves healthcare organizations, remote patient monitoring providers, diagnostic testing facilities, and medical device manufacturers with arrhythmia detection and data integration capabilities.
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $314.6K |
| National Science Foundation | Phase I | 2020 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does ZBeats do?
- ZBeats is a cardiac technology company offering FDA-cleared electrocardiographic analysis software that transforms ECG signals into structured clinical intelligence for cardiology workflows. The platform serves healthcare organizations, remote patient monitoring providers, diagnostic testing facilities, and medical device manufacturers with arrhythmia detection and data integration capabilities.
- Who are ZBeats's investors?
- ZBeats's investors include Camellia Venture Capital.